Effect of elastin-derived peptides on the production of tissue inhibitor of metalloproteinase-1, -2, and -3 and the ratios in various endothelial cell lines

Siemianowicz,Krzysztof; Likus,Wirginia; Francuz,Tomasz; Garczorz,Wojciech

doi:10.3892/etm.2015.2429

Effect of elastin-derived peptides on the production of tissue inhibitor of metalloproteinase-1, -2, and -3 and the ratios in various endothelial cell lines

Authors:
- Krzysztof Siemianowicz
- Wirginia Likus
- Tomasz Francuz
- Wojciech Garczorz
View Affiliations

Affiliations: Department of Biochemistry, School of Medicine, Medical University of Silesia, Katowice 40‑752, Poland, Department of Human Anatomy, School of Medicine, Medical University of Silesia, Katowice 40‑752, Poland
Published online on: April 17, 2015 https://doi.org/10.3892/etm.2015.2429
Pages: 2245-2250

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tissue inhibitors of metalloproteinases (TIMPs) control the activity of metalloproteinases. Elastin-derived peptides (EDPs) are generated as a result of the degradation of elastin fibers. The EDPs bind to the elastin receptor and exert numerous biological effects. The aim of the present study was to compare the production of TIMP‑1, TIMP‑2 and TIMP‑3 and their ratios in human endothelial cells (ECs) derived from three clinically important vascular localizations (coronary arteries, aorta and iliac artery), and evaluate the influence of a well‑known EDP, κ‑elastin. The highest concentration of TIMP‑1 was identified in the aortic ECs, while the lowest concentration was observed in the ECs derived from the coronary artery. The opposite pattern was observed for TIMP‑2 production. When the TIMP‑3 concentration was analyzed in the three EC lines, no statistically significant differences were observed. Application of κ‑elastin was found to decrease the TIMP‑1 concentration in the aortic ECs, while an increase in the TIMP‑1 concentration was observed in the ECs derived from the iliac artery. The most significant decrease in TIMP‑2 concentration following κ‑elastin administration was observed in the ECs obtained from the coronary arteries. Furthermore, the highest concentration of κ‑elastin resulted in an increase in TIMP‑3 production in the ECs derived from the coronary arteries. The following ratios of the TIMP concentrations were calculated: TIMP‑1/TIMP‑2, TIMP‑1/TIMP‑3 and TIMP‑2/TIMP‑3. Each ratio presented different values for the ECs obtained from the various localizations. In the majority of cases, the addition of κ‑elastin did not significantly change these proportions. Therefore, these indicators may be characteristic features that can be used to describe ECs in various clinically important vascular localizations.

View Figures

View References

1	Ganea E, Trifan M, Laslo AC, Putina G and Cristescu C: Matrix metalloproteinases: useful and deleterious. Biochem Soc Trans. 35:689–691. 2007. View Article : Google Scholar : PubMed/NCBI
2	Raffetto JD and Khalil RA: Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol. 75:346–359. 2008. View Article : Google Scholar : PubMed/NCBI
3	Troeberg L and Nagase H: Analysis of TIMP expression and activity. Methods Mol Med. 135:251–267. 2007. View Article : Google Scholar : PubMed/NCBI
4	Stetler-Stevenson WG: The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2. Cancer Metastasis Rev. 27:57–66. 2008. View Article : Google Scholar : PubMed/NCBI
5	Shen Q, Lee ES, Pitts RL, Wu MH and Yuan SY: Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells. Mol Cancer Res. 8:939–951. 2010.PubMed/NCBI
6	Seo DW, Li H, Guedez L, Wingfield PT, et al: TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell. 114:171–180. 2003. View Article : Google Scholar : PubMed/NCBI
7	Kallio JP, Hopkins-Donaldson S, Baker AH and Kahari VM: TIMP-3 promotes apoptosis in nonadherent small cell lung carcinoma cells lacking functional death receptor pathway. Int J Cancer. 128:991–996. 2011. View Article : Google Scholar : PubMed/NCBI
8	Grundy SM: National Cholesterol Education Program (NCEP) - The National Cholesterol Guidelines in 2001, Adult Treatment Panel (ATP) III: Approach to lipoprotein management in 2001 National Cholesterol Guidelines. Am J Cardiol. 90:11i–21i. 2002. View Article : Google Scholar : PubMed/NCBI
9	Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar : PubMed/NCBI
10	Hornebeck W and Robert L: Elastase-like enzymes in aortas and human breast carcinomas: quantitative variations with age and pathology. Adv Exp Med Biol. 79:145–164. 1977. View Article : Google Scholar : PubMed/NCBI
11	Gayral S, Garnotel R, Castaing-Berthou A, et al: Elastin-derived peptides potentiate atherosclerosis through the immune Neu1-PI3K൧ pathway. Cardiovasc Res. 102:118–127. 2014. View Article : Google Scholar : PubMed/NCBI
12	Gminski J and Drozdz M: Succinyl trialanine p-nitroanilide hydrolytic activities in plasma and the aorta of rabbits experimentally immunized with soluble elastin. Exp Pathol. 43:37–40. 1991. View Article : Google Scholar : PubMed/NCBI
13	Faury G, Ristori MT, Verdetti J, Jacob MP and Robert L: Effect of elastin peptides on vascular tone. J Vasc Res. 32:112–119. 1995. View Article : Google Scholar : PubMed/NCBI
14	Faury G, Garnier S, Weiss AS, et al: Action of tropoelastin and synthetic elastin sequences on vascular tone and on free Ca²⁺ level in human vascular endothelial cells. Circ Res. 82:328–336. 1998. View Article : Google Scholar : PubMed/NCBI
15	Robert L, Labat-Robert J and Robert AM: Genetic, epigenetic and posttranslational mechanisms of aging. Biogerontology. 11:387–399. 2010. View Article : Google Scholar : PubMed/NCBI
16	Siemianowicz K, Gminski J, Goss M, Francuz T, Likus W, Jurczak T and Garczorz W: Influence of elastin-derived peptides on metalloprotease production in endothelial cells. Exp Ther Med. 1:1057–1060. 2010.PubMed/NCBI
17	Robinet A, Fahem A, Cauchard J-H, et al: Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP. J Cell Sci. 118:343–356. 2005. View Article : Google Scholar : PubMed/NCBI
18	Mieczkowska J, Mosiewicz J, Barud W and Kwasniewski W: Changes in the activity of connective tissue matrix enzymes in the metabolic syndrome. Arch Med Sci. 7:634–641. 2011. View Article : Google Scholar : PubMed/NCBI
19	de la Sierra A and Larrousse M: Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension. J Hum Hypertens. 24:373–379. 2010. View Article : Google Scholar : PubMed/NCBI
20	Ragino IuI, Cherniavskiĭ AM, Polonskaia IaV, Volkov AM, Kashtanova EV, Tsymbal SIu and Polovnikova EM: Inflammatory-destructive biomarkers of atherosclerotic plaques instability. Study of arterial wall and blood. Kardiologiia. 52:37412012.(In Russian). PubMed/NCBI
21	Zou Y, Qi Y, Roztocil E and Davies MG: Patterns of gelatinase activation induced by injury in the murine femoral artery. J Surg Res. 154:135–142. 2009. View Article : Google Scholar : PubMed/NCBI
22	Zou Y, Fu Y and Davies MG: Role for Gᵝᵧ G-proteins in protease regulation during remodeling of the murine femoral artery. J Surg Res. 178:40–47. 2013. View Article : Google Scholar
23	Moore R, Hawley A, Sigler R, Farris D, Wrobleski S, Ramacciotti E and Myers D: Tissue inhibitor of metalloproteinase-1 is an early marker of acute endothelial dysfunction in a rodent model of venous oxidative injury. Ann Vasc Surg. 23:498–505. 2009. View Article : Google Scholar : PubMed/NCBI
24	Misra S, Fu AA, Misra KD, Shergill UM, Leof EB and Mukhopadhyay D: Hypoxia-induced phenotypic switch of fibroblasts to myofibroblasts through a matrix metalloproteinase 2/tissue inhibitor of metalloproteinase-mediated pathway: implications for venous neointimal hyperplasia in hemodialysis access. J Vasc Interv Radiol. 21:896–902. 2010. View Article : Google Scholar : PubMed/NCBI
25	Mammi C, la Sala A, Volterrani M, et al: Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure. Eur J Heart Fail. 13:642–650. 2011. View Article : Google Scholar : PubMed/NCBI
26	Ramirez Correa GA, Zacchigna S, Arsic N, Zentilin L, Salvi A, Sinagra G and Giacca M: Potent inhibition of arterial intimal hyperplasia by TIMP1 gene transfer using AAV vectors. Mol Ther. 9:876–884. 2004. View Article : Google Scholar : PubMed/NCBI
27	Seo DW, Saxinger WC, Guedez L, Cantelmo AR, Albini A and Stetler-Stevenson WG: An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo. Peptides. 32:1840–1848. 2011. View Article : Google Scholar : PubMed/NCBI
28	Qi JH, Ebrahem Q, Ali M, et al: Tissue inhibitor of metalloproteinases-3 peptides inhibit angiogenesis and choroidal neovascularization in mice. PLoS One. 8:e556672013. View Article : Google Scholar : PubMed/NCBI
29	Vacek TP, Gillespie W, Tyagi N, Vacek JC and Tyagi SC: Hydrogen sulfide protects against vascular remodeling from endothelial damage. Amino Acids. 39:1161–1169. 2010. View Article : Google Scholar : PubMed/NCBI
30	Basu P, Qipshidze N, Sen U, Givvimani S, Munjal C, Mishra PK and Tyagi SC: Chronic hyperhomocysteinemia causes vascular remodelling by instigating vein phenotype in artery. Arch Physiol Biochem. 117:270–282. 2011. View Article : Google Scholar : PubMed/NCBI
31	Lemaitre V, Dabo AJ and D'Armiento J: Cigarette smoke components induce matrix metalloproteinases-1 in aortic endothelial cells through inhibition of mTOR signaling. Toxicol Sci. 123:542–549. 2011. View Article : Google Scholar : PubMed/NCBI
32	George SJ, Wan S, Hu J, MacDonald R, Johnson JL and Baker AH: Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy. Circulation. 124:(Suppl). S135–S142. 2011. View Article : Google Scholar : PubMed/NCBI